Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

35.00p
   
  • Change Today:
    -0.25p
  • 52 Week High: 48.10
  • 52 Week Low: 23.25
  • Currency: UK Pounds
  • Shares Issued: 361.48m
  • Volume: 373,908
  • Market Cap: £126.52m

CREO Overview

Creo Medical was founded in 2003 as MicroOncology Ltd by Professor Chris Hancock, initially to target the treatment of cancers through use of high frequency microwave energy and dynamic matching techniques.

Key Personnel

CEO: Craig Jonathan Gulliford
CFO: Richard John Rees
Chief Technology Officer: Christopher Paul Hancock
Executive Director: David Gerard Woods
Independent Non-Executive Director: Ivonne Cantu
Independent Non-Executive Director: John Bradshaw
Non-Executive Chairman: Charles Spicer
Non-Executive Dir:

Contact Details

Address: Creo House, Unit 2 Beaufort Park, Beaufort Park Way, Chepstow, Wales, United Kingdom , NP16 5UH
Phone: +44 (0) 1291 606005
Website: http://creomedical.com/

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BZ1BLL44

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CREO Market Data

Currency UK Pounds
Share Price 35.00p
Change Today -0.25p
% Change -0.71 %
52 Week High 48.10
52 Week Low 23.25
Volume 373,908
Shares Issued 361.48m
Market Cap £126.52m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
22.05% below the market average22.05% below the market average22.05% below the market average22.05% below the market average22.05% below the market average
25% below the sector average25% below the sector average25% below the sector average25% below the sector average25% below the sector average
Price Trend
8.41% above the market average8.41% above the market average8.41% above the market average8.41% above the market average8.41% above the market average
35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average35.14% above the sector average
Income Not Available
Growth
43.57% above the market average43.57% above the market average43.57% above the market average43.57% above the market average43.57% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 03-May-2024

Time Volume / Share Price
16:31 100,000 @ 34.63p
16:27 56,000 @ 35.48p
16:20 530 @ 35.45p
16:11 200 @ 35.45p
16:08 1,408 @ 35.50p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page